Department of Radiation Oncology


Residency Training Program

Anshu K. Jain


Anshu K. Jain

Undergraduate: Economics, Duke University, Durham NC
Medical School: University of Kentucky College of Medicine, Lexington KY
Research Fellowship: Doris Duke Clinical Research Fellowship, UTSW Dallas TX
Internship: Massachusetts General Hospital, Boston MA
Residency: NYP / Columbia University College of P&S, New York, NY

Abstracts and Publications:

1. Daly ME, Le QT, Jain AK, Maxim PG, Hsu A, Loo BW, Kaplan MJ, Fischbein NJ, Colevas AD, Pinto H, Chang DT.  Intensity-Modulated Radiotherapy for Locally Advanced Cancers of the Larynx and Hypopharynx. Head Neck. 2010 Apr 29. PMID: 20848427

2. Majmudar A, Jain AK, Chaudry J, Schwartz RW. High-performance teams and the physician leader: an overview. J Surg Educ. 2010 Jul-Aug;67(4):205-9. PMID: 20816354

2. A. K. Jain, J. K. Salama, K. M. Stenson, E. Blair, E. E. Cohen, M. Witt, D. J. Haraf, E. E. Vokes. Correlation of body mass index with toxicity and survival in locoregionally advanced head and neck cancer patients treated with induction chemotherapy and concurrent chemoradiotherapy. Journal of Clinical Oncology 27:15s, 2009 (suppl; abstr 6074)
3. Jain AK, Hughes RS, Sandler AB, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J,  Muldowney NJ, Choy H. A Phase II Study of Concurrent Chemoradiotherapy with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 2009 Jun; 4(6) : 722-7. PMID: 19404213
4. Choy H, Jain AK, Moughaney J,  Curran W, Whipple G, Demas RW, Ettinger DS. A Phase I Trial of Concurrent Gemcitabine/Carboplatin or Gemcitabine/Paclitaxel and Radiation Therapy ("Ping-Pong Trial") Followed By Adjuvant Chemotherapy for Patients with Favorable Prognosis Inoperable Stage IIIA/B Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2009 Jan; 4(1) : 80-6. PMID: 19096311
5. A. K. Jain, A. K. Das, J. Cho, M. Sato, J. D. Minna, C. S. Nirodi. The Effects of Radiation and Anti-EGFR Therapy in an Isogenic Human Bronchial Epithelial Cell Line Model. Accepted for Poster and Platform Presentation. International Journal of Radiation Oncology * Biology *
Physics. 2008 Sept; 75(1): S2 (Abstract # 4) 
6. Chaudry J, Jain AK, McKenzie S, Schwartz RW. Physician Leadership: The Competencies of Change. Journal of Surgical Education. 2008. May-Jun; 65(3): 213-220, PMID: 18571135
7. R.S. Hughes, A. Sandler, A. K. Jain, A. Dowlati, L. Schwartzberg, T. Dobbs, L. Schlabach, J. Wu, N. Muldowney, H. Choy. A phase II study of concurrent chemoradiotherapy with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer. Journal of Clinical Oncology. 2008:26 (May 20 suppl; abstr 7565)

8. A. K. Jain, A. K. Das, J. Cho, M. Sato, J. D. Minna, C. S. Nirodi. Determining the Necessary Domains for Mutant EGFR-mediated Radiosensitization in an Isogenic Human Bronchial Epithelial Cell Line Model. Radiation Research (Abstr MS 308)
9. Jain AK,  Thompson JM, Chaudry J, McKenzie S, Schwartz RW. High Performance Teams for Current and Future Physician Leaders: An Introduction.  Journal of Surgical Education 2008. Mar-Apr; 65(2): 145-50, PMID: 18439540
10.  Jain AK, Thompson JM, Kelley S,  Schwartz RW.  Fundamentals of Service Lines and the Necessity of Physician-Leaders. Surgical Innovation. 2006, 13(2): 136-144, PMID: 17012155

11. Jain AK,  Moore SM, Yamaguchi K, Eling TE, and Baek SJ.  Selective Nonsteroidal Anti-Inflammatory Drugs Induce Thymosin Beta-4 and Alter Actin Cytoskeletal Organization in Human Colorectal Cancer Cells. The Journal of Pharmacology and Experimental Therapeutics. 2004, 311(3) 885-891, PMID: 15292456

  • Residency/Medical Education
  • Advanced Technology
  • Patients
  • CUMC Scene